Home Drug plan management

Keyword: Drug plan management

449 results found
Copyright_Wavebreak Media Ltd_123RF

There’s no question that Canadians value their private health benefits, even with pharmacare discussions back on the table. In a recent Abacus Data study, 78 per cent of respondents said they feel group benefits plans increase the availability and affordability of health services in Canada, as opposed to undermining universal health coverage. Furthermore, 92 per […]

Severe asthma is a complex condition that impacts between 150,000 and 250,000 Canadians, according to Vanessa Foran, president and chief executive officer of Asthma Canada, during a webinar hosted last month by Benefits Canada and supported by AstraZeneca. It’s an acute condition where people have difficulty achieving control of their disease despite proper use of […]

The amendments to the Patented Medicine Prices Review Board regulations are officially taking effect July 1, after being delayed multiple times. The changes, which were originally proposed in 2019, are the first significant update to the regulations in more than 30 years. After consulting with stakeholders, Health Canada will be moving forward with the implementation of […]

Benefits Canada is extending the deadline for entering the 2022 Workplace Benefits Awards to Friday, July 8 at 5 p.m. EST. The annual awards recognize employers and plan sponsors that are leading the way with their approaches to supporting the mental, physical and financial well-being of their employees. Enter the 2022 Workplace Benefits Awards today. This year’s […]

  • By: Staff
  • June 27, 2022 June 24, 2022
  • 09:00

As the coronavirus pandemic continues, fewer Canadian benefits plan members are making drug claims, according to Telus Health’s annual drug trends report. The report, based on the drug claims activity of more than 10 million plan members in 2021, found just 56 per cent made a claim in 2021, reflecting a decreased frequency of in-person […]

  • By: Staff
  • June 23, 2022 June 22, 2022
  • 09:00

While medications used for treating inflammatory disease accounted for just 0.7 per cent of claims across Telus Health’s Canadian block of business in 2021, they represent the largest percentage of eligible drug costs at 12.6 per cent, due to the prevalence of high-cost treatments in this drug class. By comparison, diabetes medications accounted for 12 […]

The Federal Trade Commission is launching an inquiry into the operations of pharmacy benefits managers that control access to prescription drugs for millions of Americans. The consumer protection agency will order the nation’s largest PBMs to provide a range of information and records detailing how they do business. Pharmacy benefits managers run prescription drug coverage […]

A British Columbia labour arbitration decision is providing insight on how a block level implementation of a benefits provider’s drug cost-control program violated a collective agreement in a unionized workplace. The Douglas College Faculty Association grieved the implementation of Manulife’s DrugWatch program contravened their collective agreement, which ensured “there will be no change to the […]

The coronavirus pandemic has marked a sea change in how Canadians receive health care. While just four per cent of primary care visits were conducted virtually pre-pandemic, that rose to roughly 60 per cent after the onset of the global health crisis. This represents an opportunity to reshape how health care can be delivered and, in […]

A typical patient’s journey takes plan members from the doctor to the pharmacy for medication and then leaves them on their own. But employees’ lives aren’t static, with factors like age, mental and physical health, stress and activity level having the potential to impact how effectively those medications work, said Frederic Simard, co-founder and chief […]